Extended anticoagulant therapy in venous thromboembolism: a balanced, fractional factorial, clinical vignette-based study

• Vincent ten Cate,
• Anthonie W.A. Lensing,
• Jeffrey I. Weitz,
• Jan Beyer-Westendorf,
• Philip S. Wells,
• Patrick Mismetti,
• Paolo Prandoni,
• Alexander T. Cohen,
• Bruce L. Davidson,
• Martin H. Prins

Affiliations

Vincent ten Cate

Department of Epidemiology, Maastricht University Medical Center, Maastricht, the Netherlands

Anthonie W.A. Lensing

Department of Cardiovascular Sciences, Vascular Medicine Unit, University of Padua, Padua, Italy, and Bayer AG, Wuppertal, Germany

Jeffrey I. Weitz

Thrombosis & Atherosclerosis Research Institute and McMaster University, Hamilton, Ontario, Canada

Jan Beyer-Westendorf

Thrombosis Research Unit, Department of Medicine I, Division Hematology, University Hospital “Carl Gustav Carus” Dresden, Germany

Philip S. Wells

Department of Medicine, University of Ottawa, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada

Patrick Mismetti

Clinical Research Unit, University Hospital of Saint-Etienne, Saint-Etienne, France

Paolo Prandoni

Department of Cardiovascular Sciences, Vascular Medicine Unit, University of Padua, Padua, Italy

Alexander T. Cohen

Department of Haematological Medicine, King’s College Hospital, London, UK

Bruce L. Davidson

University of Washington School of Medicine, Seattle, WA, USA

Martin H. Prins

Department of Epidemiology, Maastricht University Medical Center, Maastricht, the Netherlands